Senior medical affairs for healthcare agencies and their pharma clients. I'm a licensed pharmacist, and I do the work myself.
Or describe what you're looking for in one sentence
Agencies bring me in when their pharma clients need senior medical affairs thinking, and someone senior to do the work: scientific depth on a pitch, a licensed pharmacist to stand behind the science, the medical strategy your team builds the program around, or senior overflow when a launch lands on top of everything else. I've sat on the client side of the table, so I know what a pharma medical team expects from agency work.
I work under your agreement, to your process, and white-label where the client needs a single front. I don't hold the client relationship, I don't approach your clients directly, and I won't take work that puts me opposite you on the same account.
ScopeI work as a subcontractor under your agreement and bill hourly. Happy to be named on a proposal where that helps, and I'll sign your NDA and non-solicit.
You've won the grant. Now the program has to be delivered, alongside a full clinical practice. I run the medical operations that turn the award into a delivered program: planning, budget, timelines, faculty and vendors, medical accuracy, and reporting to funders.
ScopeI run the operations and check the medical accuracy. The program, its faculty and its scientific direction stay yours. Where I hold an industry engagement in the same therapeutic area, I disclose it before the work begins.
Each engagement is scoped to a specific clinical problem, not sold as a retainer looking for a use. Find the line that sounds like your week, then open it.
Bespoke, stress-tested launch roadmaps, scientific platform development, launch milestone playbooks, and field medical strategy, written to be executed against rather than filed. This covers new indications and label expansions, not only first launches.
How the work dividesI own the strategy, the platform and the playbook. Tactical execution runs through your agency, media and congress partners.
Talk to me about thisCanadian key external experts and rising digital investigators, scored against a weighted framework with explicit gates and a documented evidence layer so every rank can be defended internally. I don't just build static maps: in CVRM, a decade of relationships across the Canadian clinical community lets me take this from a name on a list to a conversation that goes somewhere, compliantly, across both specialist and primary care networks. Outside Canada I build the map to the same standard, without claiming the relationships.
How the work dividesI deliver the map, the scoring methodology and the engagement plan, and I can make warm introductions. Contracting and honoraria run through your compliance and procurement processes.
Talk to me about thisI design the scientific content: the objectives, the narrative arc, the steering questions that expose your clinical data gaps, faculty recommendations, and the participant pre-read. I facilitate the session as a scientific peer, then deliver a top-line summary and a decision-ready insight report, both written by me, never a transcript.
How the work dividesI work alongside your agency or meeting-logistics partner, who handle contracting, honoraria, transfer-of-value reporting and logistics. I can recommend one.
Talk to me about thisLaunch is when HCP speakers have the least real-world experience to lean on. A speaker training meeting is only worth holding if every participant leaves knowing the data and how to present it in their own talks.
I build the agenda with your medical lead, create the training materials and speaker slides, and prepare your faculty chair, including question and answer preparation that covers the off-label boundary, the competitor comparison, the subgroup question the data does not support, and pushback from the room.
Where it helps I facilitate on the day too, virtually or in person, alongside your chair and medical team rather than in place of them.
How the work dividesI design the program and build the materials, and I can facilitate the meeting where you want me in the room. Your MLR process reviews and approves everything before it is used, and speaker certification and who is approved to present stay with your team. Contracting, honoraria and transfer-of-value reporting run through your compliance and procurement processes or your meeting partner.
Talk to me about thisTeams building with AI in this sector keep hitting the same wall: the output is fluent, and nobody senior enough is willing to stand behind it clinically. That is the gap I fill. Medical review of AI-generated insights before they reach a decision, scientific accuracy in AI-assisted content so it survives your own review process, and an assessment of how your therapies are actually being represented in the AI tools that clinicians and patients now ask first. I also help shape field medical use cases so MSLs get something that holds up in front of a specialist.
How the work dividesI am the medical expert who speaks AI, not a technologist. Your team owns the model, the build and the infrastructure. I own the clinical judgement layer on top of it, and your compliance and regulatory functions run their own review.
Talk to me about thisInterim senior medical cover for when the seat is empty and the work is not: a parental leave, a structural vacancy, a departure in the middle of a launch, or a stretch that simply needs a second senior head in the room. I come in as veteran medical direction rather than as an extra pair of hands. That means chairing the medical discussion, taking the decisions that cannot wait for a permanent hire, holding the scientific line in cross-functional meetings where medical has to be the one saying no, and keeping the medical plan moving so the gap does not become a holding pattern your team has to recover from later. I have carried the role rather than advised on it, so I can take those decisions from the start rather than after a learning curve.
How the work dividesI carry defined medical director responsibilities within an agreed decision-rights boundary. Signatory authority, people management and budget ownership remain in your organization, and before I start, you and I settle exactly which decisions are mine and which come back to you.
Talk to me about this
“I have carried the role rather than advised on it.”
I'm a licensed pharmacist and former Associate Medical Director, Cardiometabolic in global pharma, where I spent over a decade in medical strategy across the obesity, type 2 diabetes and insulin portfolios. I worked on both sides of launch, on new indications and label expansions, and on pipeline assets that had not yet reached market. That's the phase where medical plans stop being documents and start being decisions.
Over that decade I built working relationships with national and regional key opinion leaders through scientific exchange and clinical trial collaboration, and designed medical strategies that reach beyond specialists into primary care and allied health. I work from Milton, Ontario, with clients in Canada and internationally.
Depth in CVRM, obesity medicine, type 2 diabetes, and GLP-1 and incretin assets. A method that travels to any therapeutic area.
Two peer-reviewed publications, in Diabetes, Obesity and Metabolism and Clinical Obesity, plus five congress abstracts across ObesityWeek, the American Diabetes Association Scientific Sessions, the International Congress on Obesity and the Canadian Journal of Diabetes.
Scientific credibility, strategic translation, and the willingness to work inside your team rather than alongside it.
A licensed pharmacist reading raw clinical evidence, not a generalist summarizing a macro template. I bring deep commercialized depth in complex cardiometabolic and incretin assets, and the pharmacology training to get to depth quickly in an unfamiliar one.
Converting complex trial data into defensible scientific platforms, sharp HCP engagement roadmaps, and aligned medical direction. Specific enough that medical, marketing and field all read it the same way.
Operating as an embedded tactical asset within your cross-functional team. Fully integrated across Medical, Marketing, Regulatory and Market Access divisions, entirely comfortable serving as the veteran medical voice to defend strategic choices.
AI does the volume. I do the judgement. My Harvard AI in Healthcare certification informs where I draw that line, and the work happens in secure environments.
Not with the tool. The question is always what a clinician, a payer or a launch team has to decide, and what evidence would move it. Anything that does not serve that decision is noise, however impressive the technology producing it.
Volume, pattern and speed: literature triage, network screening, insight clustering. Used where the task is mechanical and the gain is real, and left out where the work is interpretation.
A named pharmacist reviews what goes out, and the reasoning is documented so your team can defend it. Speed that nobody will put their name to is not speed.
AI drafts and synthesizes. It does not sign off.
Confidential material stays in controlled environments with no training on your inputs. Your pipeline does not become someone's dataset.
Methodology, weightings and sources are handed over with the deliverable, so your team can defend the conclusions internally.
On every deliverable, in writing. No ambiguity about what was machine-assisted and what was human judgement.
One sentence is enough to start. I read and reply to every inquiry myself.
One paid conversation rather than a project: a read on the Canadian cardiometabolic landscape, a launch or access question, a due diligence or investor question, or a second opinion on a position your team has already taken. Send me the question, and I will agree the length and the rate with you before anything is booked.
Working with procurement Meridian Catalyst is an Ontario corporation with a business number and HST registration, and professional liability insurance in place. Vendor onboarding is straightforward, and I invoice through the corporation. Rates are discussed on the call, once scope is clear.
